This application is based on the Partin and Han Tables originally produced based on research from the Brady Urological Institute at Johns Hopkins Hospital. Partin tables use PSA level, Gleason score, and estimated clinical stage to help physicians predict the definitive pathologic stage of prostate cancer and use this information to help decide the best course of treatment. Han tables use PSA level, Gleason score, and clinical stage to predict the probability of the first evidence of recurrence (detectable PSA level) 3, 5, 7, and 10 years following surgery. The Han table can be used both pre-operatively (based on clinical grade) and post-operatively (based on pathological stage). This app allows physicians to enter data for the variables above and immediately calculate the predicated pathologic stage (Partin) and percentage of biochemical recurrence-free survival probability at 3, 5, 7, and 10 years (Han).
Sexiness of Interface/Ease of Use:
This app has a very simple and easy to use interface set-up in typical iPhone fashion with scrolling tabs allowing for easy entry of PSA level, gleason score, and clinical staging. Results appear immediately and are easy to follow.
This app is most useful for urologists and urology residents for quick access to the Partin and Han tables without having to use a computer or a book to look up the information. For those who use these tables on a daily basis and do not have computers in exam rooms, this app is worth the $2.99 price. However, for physicians that like to print the results for patients to take home with them, it may just be easier to use the online calculators, which will allow for the results to be printed and more easily distributed to patients.
A solid app that performs the algorithm for the Partin and Han tables in a quick and easy fashion right in the physician’s pocket. Access to the information in the tables is immediate, and entering data is quite easy making this app perfect for those on the go that use these tables on a daily basis for clinical decision-making.